Far Infrared Radiation Treatment for Bipolar Condition

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Bipolar Condition

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00573196

Enrollment

Registered

2007-12-14

Start date

2006-09-30

Completion date

2008-06-30

Last updated

2009-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Keywords

Affective Psychosis, Bipolar, Depression, Bipolar, Mania, Manic Disorder, Manic State, Manic-Depressive Psychosis, Psychoses, Manic-Depressive, Psychosis, Manic-Depressive

Brief summary

A preliminary study to determine the possibility of using far infrared radiation for the treatment of the Bipolar Condition

Detailed description

A 2000 study in the American Journal of Psychiatry reported that, in those with bipolar, two major areas of the brain contain 30 percent more cells that send signals to other brain cells. This fact explains why famous people with the Bipolar condition like astronaut Buzz Aldrin, financier Robert Campeau, British Prime Minister Winston Churchill, composer Mozart, scientist Isaac Newton, physician Sigmund Freud and media giant & entrepreneur Ted Turner, excelled in life due to the additional brain power! The excessive brain power, however, had to be controlled occasionally with mood stabilizers. Mood stabilizers include a number of anticonvulsants and Lithium. These medications, however, have adverse side effects on the kidneys. The proposed evaluation does not have any adverse health effects.

Interventions

RADIATIONFar infrared

Far infrared radiation (5μm to 15μm wavelength)

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Persons with Bipolar Condition, Depression, Anxiety, Stress and Insomnia

Exclusion criteria

* Persons with severe mental illness that are confined to mental hospitals etc. as defined by the USA Diagnostic and Statistical Manual of Mental Disorders (DSM) are excluded from this clinical trial.

Design outcomes

Primary

Measure	Time frame
The primary end point is to determine the therapeutic effects of far infrared radiation on bipolar condition.	2 years

Secondary

Measure	Time frame
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other related mental illness including Depression, Anxiety, Stress and Insomnia.	2 years

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026